These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32849545)

  • 1. Corilagin Ameliorates Atherosclerosis in Peripheral Artery Disease via the Toll-Like Receptor-4 Signaling Pathway
    Li Y; Wang Y; Chen Y; Wang Y; Zhang S; Liu P; Chen Z; Song P; Luo L; Luo Y; Dang Y; Zhao L
    Front Immunol; 2020; 11():1611. PubMed ID: 32849545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corilagin relieves atherosclerosis via the toll-like receptor 4 signaling pathway in vascular smooth muscle cells.
    Wang Y; Li Y; Chen Y; Mao J; Ji J; Zhang S; Liu P; Pronyuk K; Fisher D; Dang Y; Zhao L
    Int J Immunopathol Pharmacol; 2024; 38():3946320241254083. PubMed ID: 38869980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corilagin ameliorates atherosclerosis by regulating MMP-1, -2, and -9 expression in vitro and in vivo.
    Tao Y; Zhang L; Yang R; Yang Y; Jin H; Zhang X; Hu Q; He B; Shen Z; Chen P
    Eur J Pharmacol; 2021 Sep; 906():174200. PubMed ID: 34062170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway
    Mao J; Chen Y; Zong Q; Liu C; Xie J; Wang Y; Fisher D; Hien NTT; Pronyuk K; Musabaev E; Li Y; Zhao L; Dang Y
    Front Immunol; 2024; 15():1364161. PubMed ID: 38803504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
    Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
    Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corilagin Protects Against HSV1 Encephalitis Through Inhibiting the TLR2 Signaling Pathways In Vivo and In Vitro.
    Guo YJ; Luo T; Wu F; Liu H; Li HR; Mei YW; Zhang SL; Tao JY; Dong JH; Fang Y; Zhao L
    Mol Neurobiol; 2015 Dec; 52(3):1547-1560. PubMed ID: 25367881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiatherosclerotic effects of corilagin via suppression of the LOX-1/MyD88/NF-κB signaling pathway in vivo and in vitro.
    He B; Chen D; Zhang X; Yang R; Yang Y; Chen P; Shen Z
    J Nat Med; 2022 Mar; 76(2):389-401. PubMed ID: 35064897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corilagin ameliorates the extreme inflammatory status in sepsis through TLR4 signaling pathways.
    Li HR; Liu J; Zhang SL; Luo T; Wu F; Dong JH; Guo YJ; Zhao L
    BMC Complement Altern Med; 2017 Jan; 17(1):18. PubMed ID: 28056977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Corilagin interference with IL-13/STAT6 signaling pathways in hepatic alternative activation macrophages in schistosomiasis-induced liver fibrosis in mouse model.
    Du P; Ma Q; Zhu ZD; Li G; Wang Y; Li QQ; Chen YF; Shang ZZ; Zhang J; Zhao L
    Eur J Pharmacol; 2016 Dec; 793():119-126. PubMed ID: 27845069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin inhibits inflammation and promotes atherosclerotic plaque stability via PI3K-Akt pathway activation.
    Yan H; Ma Y; Li Y; Zheng X; Lv P; Zhang Y; Li J; Ma M; Zhang L; Li C; Zhang R; Gao F; Wang H; Tao L
    Immunol Lett; 2016 Feb; 170():7-14. PubMed ID: 26681144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corilagin Counteracts IL-13Rα1 Signaling Pathway in Macrophages to Mitigate Schistosome Egg-Induced Hepatic Fibrosis.
    Li YQ; Chen YF; Dang YP; Wang Y; Shang ZZ; Ma Q; Wang YJ; Zhang J; Luo L; Li QQ; Zhao L
    Front Cell Infect Microbiol; 2017; 7():443. PubMed ID: 29094025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway.
    Geng H; Wang A; Rong G; Zhu B; Deng Y; Chen J; Zhong R
    Mol Cell Biochem; 2010 Sep; 342(1-2):201-6. PubMed ID: 20467793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages.
    Miller YI; Viriyakosol S; Worrall DS; Boullier A; Butler S; Witztum JL
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1213-9. PubMed ID: 15718493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment.
    Kapelouzou A; Giaglis S; Peroulis M; Katsimpoulas M; Moustardas P; Aravanis CV; Kostakis A; Karayannakos PE; Cokkinos DV
    J Vasc Res; 2017; 54(3):156-169. PubMed ID: 28478461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corilagin Ameliorates Con A-Induced Hepatic Injury by Restricting M1 Macrophage Polarization.
    Yan F; Cheng D; Wang H; Gao M; Zhang J; Cheng H; Wang C; Zhang H; Xiong H
    Front Immunol; 2021; 12():807509. PubMed ID: 35095894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR4 (Toll-Like Receptor 4)-Dependent Signaling Drives Extracellular Catabolism of LDL (Low-Density Lipoprotein) Aggregates.
    Singh RK; Haka AS; Asmal A; Barbosa-Lorenzi VC; Grosheva I; Chin HF; Xiong Y; Hla T; Maxfield FR
    Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):86-102. PubMed ID: 31597445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DC-SIGN and Toll-like receptor 4 mediate oxidized low-density lipoprotein-induced inflammatory responses in macrophages.
    Yang K; Liu X; Liu Y; Wang X; Cao L; Zhang X; Xu C; Shen W; Zhou T
    Sci Rep; 2017 Jun; 7(1):3296. PubMed ID: 28607410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression.
    Blich M; Golan A; Arvatz G; Sebbag A; Shafat I; Sabo E; Cohen-Kaplan V; Petcherski S; Avniel-Polak S; Eitan A; Hammerman H; Aronson D; Axelman E; Ilan N; Nussbaum G; Vlodavsky I
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):e56-65. PubMed ID: 23162016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robinin modulates TLR/NF-κB signaling pathway in oxidized LDL induced human peripheral blood mononuclear cells.
    Janeesh PA; Sasikala V; Dhanya CR; Abraham A
    Int Immunopharmacol; 2014 Jan; 18(1):191-7. PubMed ID: 24295649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.